Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrika S H Simonsson

Showing results (51-60 of 108) with videos related to

Pageof 11
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 24, 2019
Rifampicin Can Be Given as Flat-Dosing Instead of Weight-Band DosingBudi O Susanto, Robin J Svensson, Elin M Svensson, et al.
Vaccines|March 28, 2024
Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus PandemicLaurynas Mockeliunas, Rob C van Wijk, Caryn M Upton, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 4, 2023
Seasonal influence on respiratory tract infection severity including COVID-19 quantified through Markov Chain modelingRob C van Wijk, Laurynas Mockeliunas, Caryn M Upton, et al.
British Journal of Clinical Pharmacology|July 29, 2015
Population pharmacokinetics of edoxaban in patients with symptomatic deep-vein thrombosis and/or pulmonary embolism--the Hokusai-VTE phase 3 studyRonald Niebecker, Siv Jönsson, Mats O Karlsson, et al.
International Journal of Antimicrobial Agents|April 10, 2023
Model-based analysis of bactericidal activity and a new dosing strategy for optimised-dose rifampicinBudi O Susanto, Elin M Svensson, Lindsey Te Brake, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 9, 2014
Population pharmacokinetics of morphine and morphine-6-glucuronide following rectal administration--a dose escalation studyAnne Brokjær, Mads Kreilgaard, Anne Estrup Olesen, et al.
Pharmaceutical Research|January 13, 2016
A Pharmacokinetic-Pharmacodynamic Model of Morphine Exposure and Subsequent Morphine Consumption in Postoperative PainRasmus Vestergaard Juul, Joakim Nyberg, Trine Meldgaard Lund, et al.
Journal of Clinical Pharmacology|October 2, 2007
An integrated glucose-insulin model to describe oral glucose tolerance test data in type 2 diabeticsPetra M Jauslin, Hanna E Silber, Nicolas Frey, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 12, 2023
Model-informed pediatric dose selection of marzeptacog alfa (activated): An exposure matching strategyAlan Faraj, Rob C van Wijk, Linda Neuman, et al.
British Journal of Clinical Pharmacology|July 4, 2019
Individualised dosing algorithm and personalised treatment of high-dose rifampicin for tuberculosisRobin J Svensson, Katarina Niward, Lina Davies Forsman, et al.
Pageof 11

Showing results (51-60 of 108) with videos related to

Sort By:
Pageof 11
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|December 24, 2019
Rifampicin Can Be Given as Flat-Dosing Instead of Weight-Band DosingBudi O Susanto, Robin J Svensson, Elin M Svensson, et al.
Vaccines|March 28, 2024
Risk Factors for COVID-19 and Respiratory Tract Infections during the Coronavirus PandemicLaurynas Mockeliunas, Rob C van Wijk, Caryn M Upton, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 4, 2023
Seasonal influence on respiratory tract infection severity including COVID-19 quantified through Markov Chain modelingRob C van Wijk, Laurynas Mockeliunas, Caryn M Upton, et al.
British Journal of Clinical Pharmacology|July 29, 2015
Population pharmacokinetics of edoxaban in patients with symptomatic deep-vein thrombosis and/or pulmonary embolism--the Hokusai-VTE phase 3 studyRonald Niebecker, Siv Jönsson, Mats O Karlsson, et al.
International Journal of Antimicrobial Agents|April 10, 2023
Model-based analysis of bactericidal activity and a new dosing strategy for optimised-dose rifampicinBudi O Susanto, Elin M Svensson, Lindsey Te Brake, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 9, 2014
Population pharmacokinetics of morphine and morphine-6-glucuronide following rectal administration--a dose escalation studyAnne Brokjær, Mads Kreilgaard, Anne Estrup Olesen, et al.
Pharmaceutical Research|January 13, 2016
A Pharmacokinetic-Pharmacodynamic Model of Morphine Exposure and Subsequent Morphine Consumption in Postoperative PainRasmus Vestergaard Juul, Joakim Nyberg, Trine Meldgaard Lund, et al.
Journal of Clinical Pharmacology|October 2, 2007
An integrated glucose-insulin model to describe oral glucose tolerance test data in type 2 diabeticsPetra M Jauslin, Hanna E Silber, Nicolas Frey, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 12, 2023
Model-informed pediatric dose selection of marzeptacog alfa (activated): An exposure matching strategyAlan Faraj, Rob C van Wijk, Linda Neuman, et al.
British Journal of Clinical Pharmacology|July 4, 2019
Individualised dosing algorithm and personalised treatment of high-dose rifampicin for tuberculosisRobin J Svensson, Katarina Niward, Lina Davies Forsman, et al.
Pageof 11